In trading on Tuesday, the State Street SPDR S&P Biotech ETF is outperforming other ETFs, up about 3.5% on the day. Components of that ETF showing particular strength include shares of Myriad Genetics, up about 37.5% and shares of Sagimet Biosciences, up about 12.4% on the
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.